Immunology
News
EREFS value has diagnostic utility for eosinophilic esophagitis
The Eosinophilic Esophagitis Endoscopic Reference Score, or EREFS, is not only highly predictive of eosinophilic esophagitis but also its...
Conference Coverage
Busting eczema treatment myths: applying the evidence
News
FDA approves mepolizumab for use in combination with other asthma drugs
Nucala (mepolizumab) has been approved for use with other asthma medicines as maintenance therapy for patients aged 12 years and older with a...
Conference Coverage
VIDEO: MMF equals cyclophosphamide’s efficacy in sclerodermal lung disease
Key clinical point: Mycophenolate mofetil controlled scleroderma-induced interstitial lung disease as well as cyclosphosphamide did but with...
News
Off-label prescriptions frequently cause adverse events
Off-label prescribing of drugs is common and very likely to cause adverse events, particularly when no strong scientific evidence supports the off...
Conference Coverage
EADV: Another promising topical for atopic dermatitis
Key clinical point: The pipeline for nonsteroidal topical therapies for pediatric and adult atopic dermatitis shows great promise. Major finding:...
Commentary
No flu vaccine for patients with egg allergy?
Conference Coverage
EADV: Novel topical crisaborole shines in atopic dermatitis
Crisaborole topical ointment 2% b.i.d. appeared to be a safe and effective treatment for mild to moderate atopic dermatitis in children and adults...
Conference Coverage
WCD: Pramocaine is a common contact sensitizer
Pramocaine, a topical anesthetic widely used in OTC anti-itch products, turns out to be a common cause of contact sensitization.
Conference Coverage
WCD: Topical tofacitinib hits marks in atopic dermatitis
Topical tofacitinib, a Janus kinase inhibitor, may provide a novel safe and effective therapy for atopic dermatitis.
Conference Coverage
Elderly-onset atopic dermatitis is on the rise
Atopic dermatitis arising de novo in patients in their 60s or older with no history of the disease poses a diagnostic challenge, and a low...